Clinical Utility of the Nuclear-Localized AR-V7 Biomarker in CTCs in Improving Treatment Choice in Castration-Resistant Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Utility of the Nuclear-Localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-Resistant Prostate Cancer
Eur Urol 2019 Oct 21;[EPub Ahead of Print], RP Graf, M Hullings, ES Barnett, E Carbone, R Dittamore, HI ScherFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.